Journal Report

CANCER NANOTECHNOLOGY

Download PDF
Journal Information
Journal Title
CANCER NANOTECHNOLOGY
Publisher
SPRINGER WIEN
ISSN
1868-6958
E-ISSN
1868-6966
Database
Clarivate
Domain
Health Sciences, Life Sciences, Physical Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓
2018
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
The role of platelet-derived microparticles in the progression of acute myeloid leukemia and their application in cancer nanotechnology
Bahar Yazdani, Fatemeh Yari, Saeed Mohammadi
2026-11-4
Lipid nanoparticle platforms for p53-targeted cancer therapy
Ricky Madison
2026-10-23
Targeted delivery of boron depots containing immune adjuvant to achieve efficient cancer therapy via a combination of BNCT and cancer vaccine
Shanhong Mao, Hong Hu, Luoxin Long et al.
2026-10-20
Magnetically-guided hyaluronic acid-decorated PLGA nanoparticles for enhanced tumor selective doxorubicin delivery in triple-negative breast cancer
Seonmin Choi, Jawoo Lee, Hyeyoun Cho et al.
2026-10-16
Efficient delivery of DMDD by an iron-engineered mesoporous organosilica nanoplatform reshapes the breast cancer immune microenvironment via autophagy activation and immune checkpoint modulation
Jingxuan Chen, Yongfei He, Linqian Chen et al.
2026-10-15
Stem cell-derived extracellular vesicles in cancer theranostics: dual regulatory mechanisms, engineering strategies, and clinical translation
Junyuan Ji, Zunyun Wang, Zeting Li et al.
2026-10-12
Enhanced cytotoxicity in cisplatin-tolerant oral squamous cell carcinoma 3D models through nanoparticle-mediated Pt(IV) drug delivery
Ana Belén Griso-Acevedo, Francisco Navas, Catalina Berca et al.
2026-10-9
Self-assembled products from natural active compounds: mechanisms and applications in cancer therapy
Ziyang Rao, Zhen Wang, Yihan Wang et al.
2026-9-28
GE11-engineered small extracellular vesicles enable targeted delivery of miR-204 in EGFR1-positive triple-negative breast cancer cells
Kavitha Unnikrishnan, Keerthana Jaya, Sejal Patwardhan et al.
2026-9-27
PLLA–ZnO nanowire nano-vaccine orchestrates balanced Th1/Th2 immunity and confers prophylactic antitumor protection
Prashant Sharma, Bum Chul Park, Jae-Won Lee et al.
2026-9-17
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 11, 2026 08:10